Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta blockers in ischemic heart disease.

C Wilhelmsson, A Vedin

    The American Journal of Cardiology
    |July 20, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Beta blockers significantly reduce mortality in patients who survive myocardial infarction. This review of multiple trials confirms their life-saving benefits in post-heart attack care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Resource prioritization in a learning system for health care.

    The American journal of gastroenterology·2001
    Same author

    Serotonin 5-HT2A receptor binding in platelets from patients with Alzheimer's disease or vascular dementia.

    International psychogeriatrics·2001
    Same author

    Low serum sodium concentrations during treatment with citalopram in elderly patients: relationship to serum citalopram levels and to platelet serotonin 5-HT2A receptor status.

    Journal of clinical psychopharmacology·2000
    Same author

    Who determines the research agenda?--II.

    Scandinavian cardiovascular journal : SCJ·2000
    Same author

    Clarificatioin of AstraZeneca's R&D strategies.

    Science (New York, N.Y.)·2000
    Same author

    Regulation of circulating leptin in humans.

    Endocrine·1997

    Area of Science:

    • Cardiology
    • Pharmacology
    • Clinical Trials

    Background:

    • Myocardial infarction (MI) survivors face increased mortality risks.
    • Beta-blocker medications are widely used in cardiovascular care.

    Purpose of the Study:

    • To review existing clinical trials on beta-blocker efficacy after myocardial infarction.
    • To assess the impact of beta-blockers on survival rates in MI patients.

    Main Methods:

    • Systematic review of published randomized controlled trials.
    • Analysis of mortality data from key beta-blocker trials, including the timolol trial, metoprolol trial, and the Beta-Blocker Heart Attack Trial.

    Main Results:

    • Multiple randomized trials consistently demonstrate reduced mortality with beta-blocker use post-MI.

    Related Experiment Videos

  • The timolol trial showed significant mortality reduction across all randomized patients.
  • The Beta-Blocker Heart Attack Trial corroborated these findings in a U.S. population.

    • Conclusions:

    • Chronic beta-blockade therapy is associated with reduced mortality in patients surviving acute myocardial infarction.
    • Beta-blockers represent a crucial therapeutic strategy for improving long-term outcomes after MI.
    • The precise mechanism underlying beta-blocker survival benefits post-MI requires further investigation.